piribedil has been researched along with Cochlear Hearing Loss in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Portmann, M | 1 |
| Dauman, R | 1 |
1 other study available for piribedil and Cochlear Hearing Loss
| Article | Year |
|---|---|
[Pirebedil and sudden deafness].
Topics: Adult; Aged; Female; Hearing Loss, Sensorineural; Humans; Male; Middle Aged; Piperazines; Piribedil | 1985 |